Meet DIVERSA at BIOSPAIN 2026 in Bilbao We are excited to announce that DIVERSA will be attending BIOSPAIN 2026, taking place in Bilbao from September 29 to October 1, 2026. Representing DIVERSA will be María de la Fuente, PhD, Co-Founder & CEO/CSO; Abi Vázquez, [...]
A new DIVERSA brand built on our lipid-based delivery expertise and designed specifically for the needs of cosmetics, nutraceuticals and natural ingredients. Today, we are introducing Sphirence from DIVERSA for the first time: a new brand created to bring our lipid-based delivery expertise into cosmetics, [...]
DIVERSA will be at Farmaforum 2026 in Madrid on September 22–23. Meet Abi Vázquez and Paula Martínez to discuss lipid-based nanotechnology for pharma, cosmetics and nutraceuticals, and join Abi’s round table on sensitive pharmaceutical products.
DIVERSA has received First Prize in the Knowledge-Based Business Project category at Innovatia 8.3, recognising our women-led approach to turning scientific research into real-world solutions.
Meet DIVERSA at Key Biotech & Life Sciences Events – May 2026 May is a key month for innovation and partnering in biotech, nutraceuticals and life sciences. DIVERSA Technologies will be attending three major European events, actively engaging through partnering platforms and 1:1 meetings to [...]
DIVERSA has been selected to participate in the EIT Health Bridgehead Programme 2023, organized by the European Institute of Innovation and Technology (EIT). A new opportunity to expand our horizons! Last July, the EIT announced the selected healthcare scale-ups participating in the Bridgehead [...]
DIVERSA has received the “Ricardo Bescansa Martínez” prestigious award for Technology Transfer from the Galician Royal Academy of Sciences (RAGC) and the Xunta de Galicia. This award motivates us to keep working hard! The award is part of the Galician Technology Transfer Awards [...]
Prospera Biotech has joined our will to innovate through the Activa Startups program! Prospera Biotech has been granted the Activa Startups program with DIVERSA Technologies. The program aims to support collaboration between emerging small and medium enterprises (SMEs) and startups with innovation potential. The company [...]
A new article by Rojas et al. has recently been published in Nature, describing the use of a new RNA vaccine to fight against pancreatic cancer, where nanotechnology’s role has been fundamental! The encapsulation of the RNA into lipid nanoparticles has granted an efficient RNA [...]
A new paper is out! DIVERSA has participated in the development of innovative treatment for osteoarthritis in a project led by research groups from the Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS) at The University of Santiago de Compostela, and the Health Research [...]
